Suppr超能文献

一名完全性γ干扰素受体1缺乏症患儿的诊断和治疗挑战

Diagnostic and therapeutic challenges in a child with complete interferon-γ receptor 1 deficiency.

作者信息

Olbrich Peter, Martínez-Saavedra Maria Teresa, Perez-Hurtado José Maria, Sanchez Cristina, Sanchez Berta, Deswarte Caroline, Obando Ignacio, Casanova Jean-Laurent, Speckmann Carsten, Bustamante Jacinta, Rodriguez-Gallego Carlos, Neth Olaf

机构信息

Pediatric Infectious Diseases and Immunopathology Unit, Hospital Virgen del Rocio, Instituto de Biomedicina de Sevilla, Sevilla, Spain.

Department of Immunology, Gran Canaria Dr. Negrín University Hospital, Las Palmas de Gran Canaria, Spain.

出版信息

Pediatr Blood Cancer. 2015 Nov;62(11):2036-9. doi: 10.1002/pbc.25625. Epub 2015 Jul 14.

Abstract

Autosomal recessive (AR) complete Interferon-γ Receptor1 (IFN-γR1) deficiency is a rare variant of Mendelian susceptibility to mycobacterial disease (MSMD). Although hematopoietic stem cell transplantation (HSCT) remains the only curative treatment, outcomes are heterogeneous; delayed engraftment and/or graft rejection being commonly observed. This case report and literature review expands the knowledge about this rare but potentially fatal pathology, providing details regarding diagnosis, antimicrobial treatment, transplant performance, and outcome that may help to guide physicians caring for patients with AR complete IFN-γR1 or IFN-γR2 deficiency.

摘要

常染色体隐性(AR)完全性干扰素-γ受体1(IFN-γR1)缺陷是孟德尔遗传性分枝杆菌病易感性(MSMD)的一种罕见变异型。尽管造血干细胞移植(HSCT)仍然是唯一的治愈性治疗方法,但其结果存在异质性;移植延迟和/或移植物排斥很常见。本病例报告及文献综述扩展了对这种罕见但可能致命的病理学的认识,提供了有关诊断、抗菌治疗、移植过程及结果的详细信息,可能有助于指导治疗患有AR完全性IFN-γR1或IFN-γR2缺陷患者的医生。

相似文献

1
Diagnostic and therapeutic challenges in a child with complete interferon-γ receptor 1 deficiency.
Pediatr Blood Cancer. 2015 Nov;62(11):2036-9. doi: 10.1002/pbc.25625. Epub 2015 Jul 14.
2
Partial interferon-gamma receptor deficiency and non-tuberculous mycobacterial lung disease.
Tuberculosis (Edinb). 2006 Sep;86(5):382-5. doi: 10.1016/j.tube.2005.11.002. Epub 2006 May 8.
3
IFN-gamma mediates the rejection of haematopoietic stem cells in IFN-gammaR1-deficient hosts.
PLoS Med. 2008 Jan 29;5(1):e26. doi: 10.1371/journal.pmed.0050026.
4
Enhanced osteoclastogenesis in patients with MSMD due to impaired response to IFN-γ.
J Allergy Clin Immunol. 2022 Jan;149(1):252-261.e6. doi: 10.1016/j.jaci.2021.05.018. Epub 2021 Jun 24.
6
Severe disseminated mycobacterial infection in a boy with a novel mutation leading to IFN-γR2 deficiency.
J Infect. 2012 Dec;65(6):568-72. doi: 10.1016/j.jinf.2012.08.008. Epub 2012 Aug 15.
7
Inherited human IFN-γ deficiency underlies mycobacterial disease.
J Clin Invest. 2020 Jun 1;130(6):3158-3171. doi: 10.1172/JCI135460.
9
Mycobacterium simiae infection in two unrelated patients with different forms of inherited IFN-γR2 deficiency.
J Clin Immunol. 2014 Nov;34(8):904-9. doi: 10.1007/s10875-014-0085-5. Epub 2014 Aug 19.
10
Human Lentiviral Gene Therapy Restores the Cellular Phenotype of Autosomal Recessive Complete IFN-γR1 Deficiency.
Mol Ther Methods Clin Dev. 2020 Apr 11;17:785-795. doi: 10.1016/j.omtm.2020.04.002. eCollection 2020 Jun 12.

引用本文的文献

1
Genetic, immunologic, and clinical features of 830 patients with Mendelian susceptibility to mycobacterial diseases (MSMD): A systematic review.
J Allergy Clin Immunol. 2024 May;153(5):1432-1444. doi: 10.1016/j.jaci.2024.01.021. Epub 2024 Feb 8.
5
Hematopoietic Stem Cell Transplantation in Primary Immunodeficiencies Beyond Severe Combined Immunodeficiency.
J Pediatric Infect Dis Soc. 2018 Dec 26;7(suppl_2):S79-S82. doi: 10.1093/jpids/piy114.
6
Mendelian susceptibility to mycobacterial disease: 2014-2018 update.
Immunol Cell Biol. 2019 Apr;97(4):360-367. doi: 10.1111/imcb.12210. Epub 2018 Oct 25.
7
B Regulatory Cells: Players in Pregnancy and Early Life.
Int J Mol Sci. 2018 Jul 19;19(7):2099. doi: 10.3390/ijms19072099.
8
Laboratory evaluation of the IFN-γ circuit for the molecular diagnosis of Mendelian susceptibility to mycobacterial disease.
Crit Rev Clin Lab Sci. 2018 May;55(3):184-204. doi: 10.1080/10408363.2018.1444580. Epub 2018 Mar 4.
9
Impaired IFNγ-Signaling and Mycobacterial Clearance in IFNγR1-Deficient Human iPSC-Derived Macrophages.
Stem Cell Reports. 2018 Jan 9;10(1):7-16. doi: 10.1016/j.stemcr.2017.11.011. Epub 2017 Dec 14.
10
Frequency of and mycobacteria in primary immunodeficiencies.
Turk Pediatri Ars. 2017 Sep 1;52(3):138-144. doi: 10.5152/TurkPediatriArs.2017.5240. eCollection 2017 Sep.

本文引用的文献

1
Hemophagocytic lymphohistiocytosis in 2 patients with underlying IFN-γ receptor deficiency.
J Allergy Clin Immunol. 2015 Jun;135(6):1638-41. doi: 10.1016/j.jaci.2014.11.030. Epub 2015 Jan 13.
2
3
Pineal germinoma in a child with interferon-γ receptor 1 deficiency. case report and literature review.
J Clin Immunol. 2014 Nov;34(8):922-7. doi: 10.1007/s10875-014-0098-0. Epub 2014 Sep 14.
4
B-cell lymphoma in a patient with complete interferon gamma receptor 1 deficiency.
J Clin Immunol. 2013 Aug;33(6):1062-6. doi: 10.1007/s10875-013-9907-0. Epub 2013 Jun 26.
5
Partial recessive IFN-γR1 deficiency: genetic, immunological and clinical features of 14 patients from 11 kindreds.
Hum Mol Genet. 2011 Apr 15;20(8):1509-23. doi: 10.1093/hmg/ddr029. Epub 2011 Jan 25.
7
Graft-versus-host disease causes failure of donor hematopoiesis and lymphopoiesis in interferon-gamma receptor-deficient hosts.
Blood. 2008 Sep 1;112(5):2111-9. doi: 10.1182/blood-2007-12-130534. Epub 2008 Jun 13.
8
IFN-gamma mediates the rejection of haematopoietic stem cells in IFN-gammaR1-deficient hosts.
PLoS Med. 2008 Jan 29;5(1):e26. doi: 10.1371/journal.pmed.0050026.
9
Two patients with complete defects in interferon gamma receptor-dependent signaling.
J Clin Immunol. 2007 Sep;27(5):490-6. doi: 10.1007/s10875-007-9097-8. Epub 2007 May 21.
10
An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases.
Am J Respir Crit Care Med. 2007 Feb 15;175(4):367-416. doi: 10.1164/rccm.200604-571ST.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验